Oral Sodium Clodronate for Nonmetastatic Prostate Cancer--Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873) - Concepedia

Concepedia

Publication | Open Access

Oral Sodium Clodronate for Nonmetastatic Prostate Cancer--Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873)

DOI Full Paper Access

105

Citations

32

References

2007

Year

M. D. Mason, Matthew R. Sydes, J. Glaholm, Ruth E. Langley, Robert Huddart, M. Sokal, M. STOTT, A. Robinson, Nicholas D. James, Mahesh Parmar,

JNCI Journal of the National Cancer Institute

Abstract

Adjuvant sodium clodronate does not modify the natural history of nonmetastatic prostate cancer.

References

	Year	Citations

Page 1